Abstract
Nocturnal worsening of asthma is very common and employed in clinical practice as a marker of asthma severity. The fall in overnight lung function can reach 50%. Several mechanisms contribute to this circadian (24 h) variation. Cortisol, steroid responsiveness, vagal tone, leukotriene, airway inflammation and airway hyperresponsiveness vary in a circadian fashion and have been described as potential mechanisms. Studies on the ability of corticosteroids to block circadian recruitment of inflammatory cells show that a single corticosteroid systemic dose in the afternoon results in a significant pancellular reduction in bronchoalveolar lavage cytology at 4: 00 h and a reduction in the overnight fall in FEV1. The same single dose in the morning or night does not lead to significant improvement. Further studies on chronotherapy of asthma have revealed a rapid and time-dependent effect of inhaled steroids. A single dose of inhaled steroid in the afternoon has a protective effect against asthma worsening in the same night. Chronotherapeutic principles are also applied with other than corticosteroid drugs in the regular asthma treatment.
Keywords: asthma, circadian rhythm, chronotherapy, airway hyperresponsiveness, bronchial inflammation
Current Respiratory Medicine Reviews
Title: Mechanisms and Therapeutic Implications of Asthma Circadian Rhythm
Volume: 1 Issue: 2
Author(s): Elcio O. Vianna
Affiliation:
Keywords: asthma, circadian rhythm, chronotherapy, airway hyperresponsiveness, bronchial inflammation
Abstract: Nocturnal worsening of asthma is very common and employed in clinical practice as a marker of asthma severity. The fall in overnight lung function can reach 50%. Several mechanisms contribute to this circadian (24 h) variation. Cortisol, steroid responsiveness, vagal tone, leukotriene, airway inflammation and airway hyperresponsiveness vary in a circadian fashion and have been described as potential mechanisms. Studies on the ability of corticosteroids to block circadian recruitment of inflammatory cells show that a single corticosteroid systemic dose in the afternoon results in a significant pancellular reduction in bronchoalveolar lavage cytology at 4: 00 h and a reduction in the overnight fall in FEV1. The same single dose in the morning or night does not lead to significant improvement. Further studies on chronotherapy of asthma have revealed a rapid and time-dependent effect of inhaled steroids. A single dose of inhaled steroid in the afternoon has a protective effect against asthma worsening in the same night. Chronotherapeutic principles are also applied with other than corticosteroid drugs in the regular asthma treatment.
Export Options
About this article
Cite this article as:
Vianna O. Elcio, Mechanisms and Therapeutic Implications of Asthma Circadian Rhythm, Current Respiratory Medicine Reviews 2005; 1 (2) . https://dx.doi.org/10.2174/1573398054023019
DOI https://dx.doi.org/10.2174/1573398054023019 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Efficacy of a New Selective Steroid (GW870086) in Asthma: An Adaptive, Randomised, Controlled Trial
Current Drug Therapy Airway Smooth Muscle Phenotype and Function: Interactions with Current Asthma Therapies
Current Drug Targets Pharmacogenetics of the Antiplatelet Effect of Aspirin
Current Pharmaceutical Design Sex Hormones and their Analogues in Neuroimmune Biology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Treatment of Hypertensive Complications in Pregnancy
Current Pharmaceutical Design A2A Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update
Current Medicinal Chemistry Food Fortification with Omega-3 Fatty Acids; Microencapsulation as an Addition Method
Current Nutrition & Food Science Camptothecins and Lung Cancer: Improved Delivery Systems by Aerosol
Current Cancer Drug Targets Diagnostics and Therapy of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitides
Current Pharmaceutical Design Development of IL-5 Receptor Antagonists
Current Pharmaceutical Design Is the Modulation of Autophagy the Future in the Treatment of Neurodegenerative Diseases?
Current Topics in Medicinal Chemistry Green Synthesis, Characterization and Antimicrobial Activities of Copper Nanoparticles from the Rhizomes Extract of <i>Picrorhiza kurroa</i>
Pharmaceutical Nanotechnology Schistosoma mansoni Antigens as Modulators of the Allergic Inflammatory Response in Asthma
Endocrine, Metabolic & Immune Disorders - Drug Targets Microbiology of the Human Intestinal Tract and Approaches for Its Dietary Modulation
Current Pharmaceutical Design Patent Selections
Recent Patents on Cardiovascular Drug Discovery Cytokines as Targets in Chronic Obstructive Pulmonary Disease
Current Drug Targets IL-19 as a Potential Therapeutic in Autoimmune and Inflammatory Diseases
Current Pharmaceutical Design Clinical Considerations in Developing Dendritic Cell Vaccine Based Immunotherapy Protocols in Cancer
Current Molecular Medicine EGF and PDGF Receptor Tyrosine Kinases as Therapeutic Targets for Chronic Lung Diseases
Current Molecular Medicine Application of Human Placental Villous Tissue Explants to Study ABC Transporter Mediated Efflux of 2,4-Dinitrophenyl-S-Glutathione
Current Pharmaceutical Biotechnology